| Primary |
| Hiv Infection |
71.4% |
| Antiretroviral Therapy |
5.2% |
| Product Used For Unknown Indication |
2.8% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Depression |
2.0% |
| Dyspnoea |
2.0% |
| Coronary Artery Disease |
1.6% |
| Hyperlipidaemia |
1.6% |
| Abdominal Pain |
1.2% |
| Antiviral Prophylaxis |
1.2% |
| Anxiety |
1.2% |
| Fatigue |
1.2% |
| Hypertension |
1.2% |
| Insomnia |
1.2% |
| Irritable Bowel Syndrome |
1.2% |
| Antiviral Treatment |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
| Acquired Immunodeficiency Syndrome |
0.4% |
| Antifungal Prophylaxis |
0.4% |
| Blood Cholesterol |
0.4% |
|
| Vomiting |
14.5% |
| Rash |
8.1% |
| Atrial Fibrillation |
6.5% |
| Hepatic Enzyme Increased |
6.5% |
| Acute Myocardial Infarction |
4.8% |
| Cd4 Lymphocytes Decreased |
4.8% |
| Exposure During Pregnancy |
4.8% |
| Ischaemia |
4.8% |
| Pancreatic Carcinoma |
4.8% |
| Renal Failure |
4.8% |
| Renal Impairment |
4.8% |
| Swelling |
4.8% |
| Anal Cancer |
3.2% |
| Constipation |
3.2% |
| Death |
3.2% |
| Dyspepsia |
3.2% |
| Dyspnoea |
3.2% |
| Liver Disorder |
3.2% |
| Myelodysplastic Syndrome |
3.2% |
| Myocardial Infarction |
3.2% |
|
| Secondary |
| Hiv Infection |
48.6% |
| Antiretroviral Therapy |
23.5% |
| Maternal Exposure Timing Unspecified |
13.4% |
| Product Used For Unknown Indication |
2.8% |
| Foetal Exposure During Pregnancy |
2.2% |
| Antiviral Treatment |
1.7% |
| Blood Testosterone Decreased |
1.7% |
| Hypertension |
1.1% |
| Myopathy |
1.1% |
| Antifungal Prophylaxis |
0.6% |
| Back Pain |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Drug Use For Unknown Indication |
0.6% |
| Dysmenorrhoea |
0.6% |
| Fungal Infection |
0.6% |
| Infection |
0.6% |
|
| Foetal Exposure During Pregnancy |
16.7% |
| Kidney Enlargement |
14.3% |
| Cytolytic Hepatitis |
7.1% |
| Renal Failure |
7.1% |
| Abortion Spontaneous |
4.8% |
| Hepatocellular Injury |
4.8% |
| Mitochondrial Myopathy Acquired |
4.8% |
| Myelodysplastic Syndrome |
4.8% |
| Nausea |
4.8% |
| Pancreatic Carcinoma |
4.8% |
| Small For Dates Baby |
4.8% |
| Aspartate Aminotransferase Increased |
2.4% |
| Blood Creatine Phosphokinase Increased |
2.4% |
| Drug Ineffective |
2.4% |
| Exposure During Pregnancy |
2.4% |
| Live Birth |
2.4% |
| Local Swelling |
2.4% |
| Metastases To Lymph Nodes |
2.4% |
| Premature Delivery |
2.4% |
| Procedural Complication |
2.4% |
|
| Concomitant |
| Hiv Infection |
37.7% |
| Product Used For Unknown Indication |
22.5% |
| Hypertension |
4.9% |
| Maternal Exposure Timing Unspecified |
3.9% |
| Pain |
2.9% |
| Dizziness |
2.5% |
| Pulmonary Arterial Hypertension |
2.5% |
| Pulmonary Hypertension |
2.5% |
| Anticoagulant Therapy |
2.0% |
| Anxiety |
2.0% |
| Autoimmune Disorder |
2.0% |
| Cardiac Disorder |
2.0% |
| Diuretic Therapy |
2.0% |
| Supplementation Therapy |
2.0% |
| Acquired Immunodeficiency Syndrome |
1.5% |
| Anaemia |
1.5% |
| Burning Sensation |
1.5% |
| Cytomegalovirus Infection |
1.5% |
| Depression |
1.5% |
| Hepatitis C |
1.5% |
|
| Swollen Tongue |
12.9% |
| Death |
9.7% |
| Fluid Overload |
9.7% |
| Non-hodgkin's Lymphoma |
6.5% |
| Psychotic Disorder |
6.5% |
| Renal Failure Chronic |
6.5% |
| Throat Cancer |
6.5% |
| Alopecia |
3.2% |
| Asthma |
3.2% |
| Back Pain |
3.2% |
| Cholestasis Of Pregnancy |
3.2% |
| Dehydration |
3.2% |
| Diabetic Hyperosmolar Coma |
3.2% |
| Diabetic Ketoacidosis |
3.2% |
| Dry Mouth |
3.2% |
| Dyspnoea |
3.2% |
| Flushing |
3.2% |
| Granulocytopenia |
3.2% |
| Haematemesis |
3.2% |
| Headache |
3.2% |
|
| Interacting |
|
|
